Interested in submitting to this journal? We recommend that you review the About the Journal page for the journal's section policies, as well as the Author Guidelines. Authors need to register with the journal prior to submitting or, if already registered, can simply log in and begin the five-step process.




Indonesian Journal of Pharmaceutical Sciences (Jurnal Ilmu Kefarmasian Indonesia) is bi annually Journal (April and October) which publishes original research work that contributes significantly to increase the scientific knowledge in Pharmaceutics & Biopharmaceutics, Pharmaceutical Chemistry, Pharmacognosy and Phytochemistry, Pharmaceutical Microbiology and Biotechnology, Pharmacology and Toxicology, Pharmaceutical Chemistry, Pharmacovigilance, Pharmacogenomics, Community and Clinical Pharmacy. The Journal publishes original research work either as a Research article or as a Short Communication. Review Articles on a current topic in Pharmaceutical Sciences are also considered for publication by the Journal.

Manuscripts will be subjected to peer review process to determine their suitability for publication provided they fulfil the requirements of the journal as laid out in the instructions to authors. After the review, manuscripts will be returned for revision along with reviewer’s and/or editor’s comments. Prepare the manuscript in Times New Roman font using a font size of 11. There shall not be any decorative borders anywhere in the text including the title page. All the tables and figures should be in the separate file from the manuscript.

Submission of a manuscript to Indonesian Journal of Pharmaceutical Sciences for publication implies that the same work has not been either published or under consideration for publication in another Journal. Authors publishing results from in vivo experiments involving animals or humans should state whether due permission for conduction of these experiments was obtained, from the relevant ethics committees, in the Materials and Methods section. In addition, authors wishing to publish research work involving human studies should also send a notary verified letter of approval from the Ethics Committee or the Institutional Review Board.

Manuscript should be divided into Title page, Abstract, Introduction, Materials and Methods, Results & Discussion, Conclusion, Acknowledgement, References.

Title page- In separate lines, title page should contain the title of the manuscript, the name(s) and affiliation(s) of the author(s), and the mailing address, telephone, and e-mail address of the corresponding author.

The title must be specific, concise and informative (maximum 20 words)




Keywords and abstract- Please include 3-6 keywords for indexing purposes; Full-length manuscript submission should contain an abstract of up to 200 words in a structured form, consisting of: Background, Objective, Methods, Results, and Conclusion.  



Introduction- It should summarize the rationale, provides a concise research background (not an exhaustive review) and states in single sentence the objective of the study. Please do not include any results or the conclusion of the study.

Materials and methods- All the ethical permission associated in the research work must be specified. It should provide technical information about the study. Published methodological details are not needed to describe that have been published previously. Specifications (including the manufacturer, city, and the country) should be given for the main drugs, chemicals, and instruments. Indicate the statistical methods used and identify statistical significance using superscripts (* and **) following the data (*P<0.05, **P <0.01).

Results & Discussion- It should reveal the findings of works. It should be with the interpretation of the results and their comparison with those of other studies. No need to repeat the results, review literature, textbook knowledge or cite references that do not have a close relationship with the present result.

Conclusion – This should state clearly the main conclusions and provide an explanation of the importance and relevance of the study reported.

ACKNOWLEDGEMENTS - This chapter could be added if needed, used for mentioning sources of research funds whose results are reported in this journal and give awards to several institutions or people who help carry out research and/or write reports.

Please add: “This research did not receive any specific grant from funding agencies in the public, commercial, or not-for profit sectors.g” or “This research was funded by NAME OF FUNDER, grant number XXX” and “The APC was funded by XXX”.



When preparing tables, please follow the formatting instructions below.

  • Tables should be numbered and cited in the text in sequence using Arabic numerals (i.e. Table 1., Table 2. etc.).
  • Tables less than one A4 or Letter page in length can be placed in the appropriate location within the manuscript.
  • Tables larger than one A4 or Letter page in length can be placed at the end of the document text file. Please cite and indicate where the table should appear at the relevant location in the text file so that the table can be added in the correct place during production.
  • Tables should not be embedded as figures or spreadsheet files, but should be formatted using ‘Table object’ function in your word processing program.
  • Colour and shading may not be used. Parts of the table can be highlighted using superscript, numbering, lettering, symbols or bold text, the meaning of which should be explained in a table legend.


Table 1. Evaluasi tablet ---(10 font size, times new roman, normal, bold)

Figures -

Figure 1. ---(10 font size, times new roman, normal, bold)

When preparing figures, please follow the formatting instructions below.

  • Figures should be provided as separate files, not embedded in the main manuscript file.
  • Each figure of a manuscript should be submitted as a single file that fits on a single page in portrait format.
  • Multi-panel figures (those with parts a, b, c, d etc.) should be submitted as a single composite file that contains all parts of the figure.
  • Figures should be numbered in the order they are first mentioned in the text, and uploaded in this order.
  • Figure keys should be incorporated into the graphic, not into the legend of the figure.
  • Each figure should be closely cropped to minimize the amount of white space surrounding the illustration. Cropping figures improves accuracy when placing the figure in combination with other elements when the accepted manuscript is prepared for publication on our site. For more information on individual figure file formats, see our detailed instructions.
  • Please note that it is the responsibility of the author(s) to obtain permission from the copyright holder to reproduce figures (or tables) that have previously been published elsewhere. In order for all figures to be open access, authors must have permission from the rights holder if they wish to include images that have been published elsewhere in non open access journals. Permission should be indicated in the figure legend, and the original source included in the reference list.





References should be numbered consecutively as like Vancouver in the order in which they are first mentioned in the text (not in alphabetic order). Identify references in text, tables, and legends by Arabic numerals in parenthesis/bracket like- [1]. References cited only in tables or figure legends should be numbered in accordance with the sequence established by the first identification in the text of the particular table or figure. Use the style of the examples below. Use complete name of the journal for non-indexed journals. Avoid using abstracts as references. Information from manuscripts submitted but not accepted should be cited in the text as “unpublished observations” with written permission from the source.

  1. Article in Journal

Cheeptham N, Phay N, Higashiyama T, Fukushi E, Matsuura, Mikawa T, et al. Studies on an antifungi antibiotic from Ellisiodothis inguinans L1588-A8. Thai J Biotechnol. 1991.1(1):37-45. .  List the first six contributors followed by et al.


  1. Book

Torssell KGB. Natural Product chemistry a mechanistic and biosynthetic approach to secondary metabolism. New York: John Wiley & Sons Limited; 1983. p. 26-57. Skoog DA. Principles of instrumental analysis. 3rd  ed. New York: Saunders College Publlishing; 1985. p. 234-5.


  1. Chapter in a Book

Suffness M and Pezzuto JM. Assay related to cancer drug discovey. In: Dey PM and Harborne JB, editors. Methods in plant biochemistry. London: Academic Press; 1991. p. 71-133.


  1. Abstract

Choudhary R. Role of phytohormones on the cultivar and essential oil of Ocimum canum Sims, a potential source of citral [abstract]. Indian parfum 1989;33:224-7 (Chem Abstr 1991:114, 37669y).


  1. Proceeding

Sumatra M. Bioassai in vitro dengan sel leukemia L 1210, sebuah metode skrining zat antitumor dari bahan alam. Prosiding Seminar Bioteknologi Kelautan Indonesia 1, Jakarta 14-15 Oktober,1998:183-88.


  1. Skripsi/Thesis/Dissertation

Cairns RB. Infrared spectroscopic studies of solid oxygen [dissertation]. Barkeley: University of California; 1965. p.156. Sofiah S. Formulasi dan teknologi tablet nitrofurantoin serta evaluasi mutu dan ketersediaan hayatinya [tesis]. Bandung: Jurusan Farmasi Institut Teknologi Bandung; 1996. hal. 60-7.


  1. Article in Internet

Morse SS. Factors in the emergence of infections disease. Emerg Infect Dis[serial online]. 1995 Jan-Mar;1(1): [24 tayangan] diambil dari URL:http://www/cdc/gov/ncidoc/EID/eid.htm. diakses 25 Desember, 1999. LaPorte RE, Marler E, Akazawa S, Sauer F. The death of biomedical journals. BMJ [serial online]. 1995;310:1387-90. diambil dari http://www. diakses 26 Juli, 1996.


  1. Web

Hoffman DL. St John’s Wort. 1995;[4 tayangan]. diambil dari: URL:http:// diakses 16 Juli, 1998. Health on the net foundation. Health on the net foundation code of conduct (HONcode) for medical and health websites. diambil dati: diakses 30 Juni, 1998.